Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT: a secondary analysis of an RCT.

ABSTRACT:

SUBMITTER: Xue R 

PROVIDER: S-EPMC11840129 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature